Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

PanOptica
150 Morristown Road, Suite 205
Bernardsville, NJ 07924
Phone: 908-766-2202

PanOptica, Inc., is a private biopharmaceutical company focused on developing innovative ophthalmology therapies. Investors include Third Rock Ventures, Novo Ventures, and SV Life Sciences. The company was co-founded by Paul Chaney, past president of OSI-Eyetech, and Martin Wax, MD, a noted academic clinician scientist working in glaucoma, and most recently vice president of research and development and head of ophthalmology discovery and pre-clinical development at Alcon Labs, Inc. The company seeks early-stage assets translated from other diseases and develops select candidates through human clinical proof of concept.

Key Contact
Name
Paul G. Chaney
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/09/17 $11,000,000 Series B Third Rock Ventures
undisclosed


Featured Reading